Fresenius SE & Co. KGaA
FSNUY
Updated: 22/09/2026, 13:03:40
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
No summaries found.
- Share price
- $13.09
- Market cap
- $117.96B
- Exchange
- OTC
- Currency
- USD
- CEO
- Michael Sen
- Employees
- 178,394
- IPO date
- 15/05/2012
- Beta
- 0.834
- Last dividend
- $0.00
- Day range
- $13.00 – $13.74
- 52-week range
- $10.33 – $33.93
- 1-day performance
- -1.21%
- 1-year performance
- 26.72%
- Current drawdown (1Y)
- -61.42%
- CIK
- 0000904868
- CUSIP
- 35804M105
- ISIN
- US35804M1053
- Created
- 07/12/2025, 04:06:36
- Last update
- 22/09/2026, 13:03:40
Track Fresenius SE & Co. KGaA with an AI analyst
See which prediction-market events move FSNUY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.